LVTTF 0.00 Stock Price Levitee Labs Inc.
Range: | 1.0E-6-0.0027 | Vol Avg: | 0 | Last Div: | 0 | Changes: | 0 |
Beta: | 0 | Cap: | 0.88B | Currency: | USD | Exchange: | PNK |
Sector: | Healthcare | IPO: | Thu Aug 12 2021 | Empoloyees: | |
CUSIP: | | CIK: | | ISIN: | CA5274241051 | Country: | CA |
CEO: | Mr. David Bentil | Website: | https://www.leviteelabs.com |
Levitee Labs Inc., a multidisciplinary integrative wellness company, provides evidence-based alternative medicines and novel psychedelic therapies. The company operates through two segments, Medical Services and Selling Products. It offers treatments and medications for substance use disorders and chronic pain, such as myofascial pain, fibromyalgia, neuropathy, and chronic regional pain syndrome, as well as hepatitis-C and mental health conditions. The company operates five clinics under the Levitee Clinics name; and three pharmacies in Alberta under the Levitee Pharmacies name. In addition, it offers electronic-prescriptions in the addiction treatment space under the BlockMD name; and wholesales supplements and superfood under the Earth Circle Organics name. The company was formerly known as Fibonacci Capital Corp. and changed its name to Levitee Labs Inc. in November 30, 2020. Levitee Labs Inc. was incorporated in 2019 and is based in Vancouver, Canada.
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.